Inventor

KANOUNI TOUFIKE

US89 patents

⚠️ This page may combine multiple inventors who share the name “KANOUNI TOUFIKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELGENE QUANTICEL RES INC

32 patents

US11084793B2Aug 10, 2021

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC3 citations84

US10207999B2Feb 19, 2019

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations84

US10202381B2Feb 12, 2019

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC4 citations84

US10112940B2Oct 30, 2018

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC4 citations84

US10023543B2Jul 17, 2018

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations84

US9776974B2Oct 3, 2017

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations84

US9771329B2Sep 26, 2017

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC6 citations84

US9725441B2Aug 8, 2017

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC2 citations84

US10316016B2Jun 11, 2019

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations83

US10047069B2Aug 14, 2018

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations83

US9828358B2Nov 28, 2017

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC5 citations83

US11890275B2Feb 6, 2024

Therapeutic compounds

CELGENE QUANTICEL RES INC1 citations73

US11535616B2Dec 27, 2022

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC2 citations73

US11214542B2Jan 4, 2022

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US11020380B2Jun 1, 2021

Therapeutic compounds

CELGENE QUANTICEL RES INC2 citations73

US10815234B2Oct 27, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC2 citations73

US10807956B2Oct 20, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10654810B2May 19, 2020

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations73

US10617680B2Apr 14, 2020

Therapeutic compounds

CELGENE QUANTICEL RES INC3 citations73

US10611763B2Apr 7, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC2 citations73

US10597365B2Mar 24, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10597376B2Mar 24, 2020

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC1 citations73

US10385051B2Aug 20, 2019

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations73

US10208039B2Feb 19, 2019

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC4 citations73

US10179769B2Jan 15, 2019

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10030017B2Jul 24, 2018

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC4 citations73

US9822119B2Nov 21, 2017

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC3 citations73

US10703739B2Jul 7, 2020

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations72

US12172998B2Dec 24, 2024

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations63

US11987560B2May 21, 2024

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC0 citations63

US9828343B2Nov 28, 2017

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations63

US9611221B2Apr 4, 2017

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations63

QUANTICEL PHARMACEUTICALS INC

9 patents

US9255097B2Feb 9, 2016

Inhibitors of lysine specific demethylase-1

QUANTICEL PHARMACEUTICALS INC29 citations98

US8952151B2Feb 10, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC21 citations96

US9573930B2Feb 21, 2017

Inhibitors of lysine specific demethylase-1

QUANTICEL PHARMACEUTICALS INC15 citations93

US9447045B2Sep 20, 2016

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC20 citations93

US9085534B2Jul 21, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC8 citations93

US9643965B2May 9, 2017

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC6 citations84

US9133166B2Sep 15, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC10 citations84

US11639333B2May 2, 2023

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC0 citations63

US9527829B2Dec 27, 2016

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC2 citations63

KINNATE BIOPHARMA INC

7 patents

US10927111B2Feb 23, 2021

Inhibitors of RAF kinases

KINNATE BIOPHARMA INC9 citations85

US11407737B2Aug 9, 2022

Inhibitors of RAF kinases

KINNATE BIOPHARMA INC8 citations84

US11377431B2Jul 5, 2022

Inhibitors of RAF kinases

KINNATE BIOPHARMA INC7 citations84

US11098031B1Aug 24, 2021

Inhibitors of RAF kinases

KINNATE BIOPHARMA INC12 citations84

US11345681B1May 31, 2022

Inhibitors of fibroblast growth factor receptor kinases

KINNATE BIOPHARMA INC4 citations72

US10894788B2Jan 19, 2021

Inhibitors of cyclin-dependent kinases

KINNATE BIOPHARMA INC5 citations72

US11780862B2Oct 10, 2023

Inhibitors of MEK kinase

KINNATE BIOPHARMA INC2 citations70

PF MEDICAMENT

1 patent

US12312336B2May 27, 2025

Inhibitors of RAF kinases

PF MEDICAMENT2 citations74

FORWARD THERAPEUTICS INC

1 patent

US12521368B2Jan 13, 2026

Modulators of TNF-alpha activity

FORWARD THERAPEUTICS INC1 citations63

Showing the top 50 of 89 patents by PatentIndex Score.